ING Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

ING Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-58,828	Closed	-$461K	–	701
2014 Q1	$461K	Hold	58,828	–	–	﹤0.01%	613
2013 Q4	$520K	Hold	58,828	–	–	﹤0.01%	598
2013 Q3	$493K	Hold	58,828	–	–	﹤0.01%	614
2013 Q2	$438K	Buy	+58,828	New	+$451K	﹤0.01%	600

Other funds holding SPPI

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

ING Group's SPPI Position: Q2 2014 in Review

ING Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2014, closing a stake of 58,828 shares — an estimated $461K sold.

ING Group first reported a position in SPPI in Q2 2013 and held it in 4 quarters. The position peaked at $520K in Q4 2013. 126 funds tracked by Wall St. Rank hold SPPI as of Q2 2014.

ING Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
ING Group sold 58,828 Spectrum Pharmaceuticals Inc shares in Q2 2014, an estimated $461K.
ING Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
ING Group's Spectrum Pharmaceuticals Inc position peaked at $520K in Q4 2013.
126 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2014.

Based on ING Group's 13F filing for Q2 2014, filed 14 Aug 2014.